Pursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, this is to inform you that Mr. Manoj Lodha has resigned as the Chief Financial Officer ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and 0.2 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sudarshan Pharma Industries Ltd has informed the stock exchanges that Mr. Manoj Lodha has resigned as the Chief Financial Officer of the company, effective 5th August 2025. The disclosure was made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The company confirmed that Mr. Lodha is not related to any directors on the board. The filing was signed by Hemal Mehta, Chairman & Managing Director.
The sudden departure of the CFO may raise short-term governance concerns among investors, but no reason for the resignation has been disclosed. Shareholders should watch for the appointment of a new CFO, as leadership gaps in finance can affect financial reporting and investor confidence.